Barclays PLC Purchases 2,253,431 Shares of Amrize Ltd $AMRZ

Barclays PLC boosted its position in Amrize Ltd (NYSE:AMRZ) by 95.4% in the 4th quarter, HoldingsChannel.com reports. The firm owned 4,614,593 shares of the company’s stock after buying an additional 2,253,431 shares during the period. Barclays PLC’s holdings in Amrize were worth $249,557,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also added to or reduced their stakes in the company. Public Sector Pension Investment Board boosted its stake in Amrize by 8.8% in the 3rd quarter. Public Sector Pension Investment Board now owns 306,957 shares of the company’s stock valued at $14,811,000 after purchasing an additional 24,738 shares during the period. Allspring Global Investments Holdings LLC boosted its stake in Amrize by 4.9% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 4,601,319 shares of the company’s stock valued at $255,051,000 after purchasing an additional 214,393 shares during the period. 111 Capital bought a new stake in Amrize in the 3rd quarter valued at $996,000. J. Safra Sarasin Holding AG boosted its stake in Amrize by 31.3% in the 4th quarter. J. Safra Sarasin Holding AG now owns 112,250 shares of the company’s stock valued at $6,174,000 after purchasing an additional 26,755 shares during the period. Finally, Savvy Advisors Inc. bought a new stake in Amrize in the 4th quarter valued at $1,960,000.

Amrize Stock Performance

NYSE:AMRZ opened at $53.19 on Monday. The stock has a fifty day moving average price of $54.07 and a 200-day moving average price of $55.50. The company has a market cap of $29.42 billion and a price-to-earnings ratio of 25.45. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. Amrize Ltd has a fifty-two week low of $44.12 and a fifty-two week high of $65.94.

Amrize (NYSE:AMRZ) last released its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.14) by ($0.02). The company had revenue of $2.18 billion for the quarter. Amrize had a net margin of 9.70% and a return on equity of 9.84%. The firm’s quarterly revenue was up 4.7% compared to the same quarter last year. As a group, equities analysts anticipate that Amrize Ltd will post 2.76 EPS for the current fiscal year.

Amrize Cuts Dividend

The firm also recently disclosed a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is currently 21.05%.

Insiders Place Their Bets

In other Amrize news, CEO Jan Philipp Jenisch acquired 3,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 19th. The stock was acquired at an average cost of $49.96 per share, for a total transaction of $149,880.00. Following the transaction, the chief executive officer directly owned 515,000 shares in the company, valued at $25,729,400. This represents a 0.59% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. Also, CTO Roald Brouwer acquired 1,500 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were acquired at an average price of $49.84 per share, with a total value of $74,760.00. Following the completion of the transaction, the chief technology officer owned 19,757 shares in the company, valued at $984,688.88. The trade was a 8.22% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders have acquired 54,920 shares of company stock valued at $2,717,429 in the last quarter. Corporate insiders own 0.54% of the company’s stock.

Analyst Ratings Changes

AMRZ has been the subject of several recent research reports. Oppenheimer set a $68.00 price target on Amrize in a research note on Friday, May 1st. Morgan Stanley restated an “overweight” rating and issued a $65.00 price target on shares of Amrize in a research note on Wednesday, May 6th. Truist Financial cut their target price on Amrize from $75.00 to $65.00 and set a “buy” rating for the company in a research report on Friday, May 1st. Wall Street Zen upgraded Amrize from a “sell” rating to a “hold” rating in a research report on Sunday, March 1st. Finally, Stephens reiterated an “overweight” rating and set a $65.00 target price on shares of Amrize in a research report on Monday, May 18th. One investment analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and six have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $64.86.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.